| Prev Close | 38.01 |
| Open | 37.92 |
| Day Low/High | 37.80 / 38.74 |
| 52 Wk Low/High | 35.34 / 50.90 |
| Volume | 953.18K |
Perrigo Co. Plc (PRGO)
37.94
0.07
0.18
NYSE
| Exchange | NYSE |
| Shares Outstanding | 133.77B |
| Market Cap | 5.17B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
It's Scary Down There: Buying at the Lows
Get paid very well for making the 'uncomfortable' play others are afraid to take.
It's Scary Down There: Buying at the Lows
Get paid very well for making the 'uncomfortable' play others are afraid to take.
Cramer: Papa's Got a Brand New Bag, and Leaves Perrigo Holding the Old One
Everything about the CEO's move to Valeant stinks.
The Trader Daily: Volatility Cuts Both Ways
Trying to exploit the PRGO-VRX dealings could leave you with a losing hand.
Jim Cramer Says There are a Lot of Questions Around Perrigo, Valeant
Jim Cramer says there are still a lot of questions around Valeant, which named a new CEO, Joseph Papa today.
Valeant Names Perrigo's Joseph Papa Chairman and CEO; Shares Jump
Valeant delighted shareholders Monday with news that Perrigo's Joseph Papa is getting into the driver's seat.
U.S. Stocks Open Lower, Earnings and Fed in the Spotlight
U.S. stocks opened lower Monday morning in a busy week for economic and earnings news.
2 Value Stocks That Are Still in Play
Perrigo is in a CEO battle, while Bunge has undergone a quiet rise.
Valeant's Shares Could Rebound if Papa Named New CEO, Analysts Say
Wall Street is confident that Valeant can turn around its steep share price decline with the right successor as CEO.
The Valeant Saga Triggers Buying Opportunities in Biotech Stocks
Other companies have suffered following the debacle.
Valeant Triggers Buying Opportunities
Other companies have suffered following the debacle.
Bearish Signals Are Rising
The market went too far, too fast.
You Can Be Data Dependent, Too
The Fed isn't the only one that can use facts in shaping decisions.
Dinged Perrigo Presents Prime Opportunity
Its best entry points over the last nine years looked very similar to the company's current valuation.
Virtual Reality Hype Carries Nvidia to Top of S&P 500 off Earnings Beat
Excitement surrounding 3D-technology appears to be paying off for Nvidia.
Generic Drug ETF Offering Portfolio Cure
With biotech stocks getting smashed on the stock market and big pharma getting hammered on the presidential campaign trail, generic drug stocks look awfully appealing.
China Drives Another Nail in the Coffins of GNC and Vitamin Shoppe
Stand-alone vitamin and supplement shops like GNC and Vitamin Shoppe shares will continue to fall in light of a Justice Department investigation.
2 Safe and Cheap Health Care Stocks
These two will continue to churn out earnings growth.
Bear Chart of the Day: Perrigo
Buying it here would be like trying to catch a falling knife.
Mylan Plans Hostile Takeover of Perrigo; Stocks Rebound in Rally
Mylan (MYL) gained ground Tuesday after it announced plans to start a $27.1 billion hostile takeover of Perrigo (PRGO).
U.S. Stocks Open Lower as Personal Income and Spending Climb
U.S. stocks opened lower Friday as personal income and spending both rose in July.
Rising Rates Won’t Slow Deal Flow Says Kellner Fund Manager
Deal flow has been massive in the first half of 2015 from healthcare to technology to insurance.
Strong Economy Will Push Israeli Stocks Higher Says Aberdeen Fund Manager
The Israeli economy is strong, growing fast and offers good value, according to William Scholes, investment manager for Aberdeen Asset management.
Health Care Mergers Are Just Getting Started
Deals coming fast and furious in the best group in town.
Deluge of Deals Isn't About to Dry Up
Acquisitions cut into overabundance of companies.
Rising Interest Rate Environment Won't Derail Merger Fund
The Merger Fund seeks absolute returns and is not correlated to the stock market so it will fare well in a rising rate environment.
Dealmaking Frenzy Leads to Heady Days for Event-Driven Funds
The surge in deal-making has created the ideal environment for merger arbitrage or event-driven funds, said K.C. Nelson, portfolio manager for the Driehaus Event Driven Fund.
